Home LiteratureArticle Details
PMID: 1495526 Published · ppublish English Clinical Trial Comment Editorial

The prevention of heart failure--a new agenda.

The New England journal of medicine ·Vol. 327 ·No. 10 ·1992-09-03 ·Pages 725-7

Cohn JN

Abstract

暂无摘要

MeSH Terms
Angiotensin-Converting Enzyme Inhibitors/therapeutic use Captopril/therapeutic use Cardiovascular Diseases/mortality Enalapril/therapeutic use Follow-Up Studies Heart Failure/prevention & control Humans Myocardial Infarction/complications Ventricular Function, Left
Chemicals
Angiotensin-Converting Enzyme Inhibitors Enalapril Captopril
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Cohn J N
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
DOI
10.1056/NEJM199209033271010
Published
1992-09-03
Pages
725-7
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
ErratumIn
-
CommentOn
PMID: 1386652
CommentOn
PMID: 1463530
CommentOn
PMID: 1495520
External Links
PubMed source DOI: 10.1056/NEJM199209033271010 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2